Gain Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Gain Therapeutics

15/11/2024 14:07

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 17 cents​​ per share for the quarter ended September 30,
higher than the same quarter last year, when the company
reported EPS of -37 cents.  The mean expectation of
five analysts for the quarter was for a loss of 21 cents per
share. Wall Street expected results to range from -23 cents
to -18 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 17 cents​.
    * The company reported a quarterly loss of $4.49 million.
    * Gain Therapeutics Inc shares had fallen by 2.0% this
quarter and
lost 46.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 2.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Gain Therapeutics
Inc is 8.00 
This summary was machine generated from LSEG data November 15 at
02:07 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.21          -0.17          Beat
 Jun. 30 2024      -0.20          -0.42          Missed
 Mar. 31 2024      -0.29          -0.22          Beat
 Dec. 31 2023      -0.32          -0.36          Missed